Suzhou Frontage New Drug Development Co., Ltd. – FDA Inspection, Mar 13, 2026

Record Details

This FDA Inspection record concerns Suzhou Frontage New Drug Development Co., Ltd., with an inspection on March 13, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Suzhou Frontage New Drug Development Co., Ltd.
Inspection Date: March 13, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
People: Kathryn L. Suttling (Company Rep)
Kathryn Suttling

View Company Profile

ID · dfb504a5-4763-471b-be43-e38006169f1b

Inspection Facts

Inspection number: 1312616
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Suzhou Frontage New Drug Development Co., Ltd.

FDA Inspection

Suzhou Frontage New Drug Development Co., Ltd.March 13, 2026

Suzhou Frontage New Drug Development Co., Ltd. – FDA Inspection, Mar 13, 2026

Record Details

This FDA Inspection record concerns Suzhou Frontage New Drug Development Co., Ltd., with an inspection on March 13, 2026, issued by the Office of Inspections and Investigations, covering human drugs.